T

TherapeuticsMD

TXMD

1.66000
USD
-0.1
(-5.68%)
Market Closed
Volume
1
EPS
0
Div Yield
0
P/E
-4
Market Cap
17,759,945
Related Instruments
ABBV
4.380
(2.36%)
189.700 USD
B
BHC
0.07000
(1.16%)
6.10000 USD
C
CRBP
-0.500
(-0.84%)
59.160 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
PFE
0.115
(0.38%)
30.650 USD
T
TEVA
0.100
(0.57%)
17.530 USD
News

Title: TherapeuticsMD

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.